The Clinical and Economic Impacts of e-Heath on Diabetes

Diabetes Mellitus, Type 2 Clinical Trial

— eHealthDM  

Official title:

The Clinical and Economic Impacts of e-Heath on Diabetes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01595269
• Other study ID #: LAWSON-686
• Status: Completed
• Phase: N/A
• First received: March 3, 2011
• Last updated: May 8, 2012
• Start date: April 2007
• Est. completion date: December 2009

Study information

• Verified date: May 2012
• Source: Pacaud, Danièle, M.D.
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Health Canada
• Study type: Interventional

Clinical Trial Summary

This project addresses the following Null Hypotheses:

1. There will be no difference will be found in the use of the search engine and the information accessed among the three education modes.

2. There will be no difference in education mode's effect on metabolic control, self-care management practices, and medical resource utilization.

3. There will be no difference in the economic impact on the health care system based on differing education modes.

Description:

In addition to the face-to-face education process currently used at the CHR, this project will develop two modes of eHealth education. Education mode 1 (control) is comprised of participants educated using CHR's current traditional face-to-face delivery method, with printed materials and written log journals. These participants will be trained to use the University's web portal if they elect to access internet-based diabetes information. This allows for the tracking of the type and amounts of diabetes information accessed by participants. Education mode 2 (static interface) participants will be educated using digitized forms of the traditional materials provided by CHR as well as an electronic log journal (e-journal) where participants will record their diabetes-related outcomes and behavioural information. Education mode 2 will be assessed and approved by CHR. Education mode 3 (dynamic interface) participants will be educated using the digitized traditional materials from education mode 2 as well as an enhanced dynamic e-journal (visualization of blood glucose and alerts). In addition, this mode will provide informative disease-related internet sites and diabetes news and articles vetted by the medical team. Participants and health professionals will then be able to electronically discuss the content and quality of this information (discussion board). New sites and articles will be added on an ongoing basis. Participants will also have access to a chat room that will encourage information sharing with other education mode 3 participants and health professionals at CHR. Education mode 3 will be assessed and approved by CHR.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 79
• Est. completion date: December 2009
• Est. primary completion date: December 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Aged 18 or older

• Literate

• Not participating in other clinical trials

• Diabetes diagnosed within the last three months

• Type 2 diabetes

• No medical conditions that could compromise metabolic control

• No linguistic, cognitive or psychosocial barriers that would hinder study completion

• Computer and internet literate

• Access to high-speed internet

Exclusion Criteria:

• Under the age of 18

• Not literate

• Participating in other clinical trials

• Diabetes diagnosed greater than three months ago

• Type 1 diabetes

• Gestational diabetes

• Additional medical conditions that could compromise metabolic control

• Linguistic, cognitive or psychosocial barriers that would hinder study completion

• Not computer and internet literate

• No access to high-speed internet

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Diabetes Mellitus
• Diabetes Mellitus, Type 2

Intervention

Other:
• eHealth education
In addition to the face-to-face education process currently used at the CHR, Education mode 1 (control), Education mode 2 (static interface) and Education mode 3 (dynamic interface) will be used.

Locations

Country	Name	City	State
Canada	Calgary Health Region's offices across southwestern Alberta	Lethbridge	Alberta

Sponsors (2)

Lead Sponsor	Collaborator
Dr. Danièle Pacaud	The Lawson Foundation

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in A1C	A1C is a measure of metabolic control in diabetes. For this study changes in A1C from baseline to 3, 6, 9 and 12 months were measured. All A1C were measured in provincial laboratories using 6.1% as the upper limit of normal for individuals without diabetes.	baseline, 3, 6, 9, 12 months	No
Secondary	a reduction in the cost of delivering health information and education processes	Secondary effects could include a change in the cost of delivering health information and education processes. Potential changes to self-care management practices of people with type II diabetes could lead to a reduced utilization of the heath care system resulting in a positive economic impact.	baseline and 12 months	No
Secondary	Changes in Diabetes Knowledge	Changes in diabetes knowledge from baseline to 3, 6, 9, and 12 months will be measured using a 23 item multiple choice questionnaire devolopped by Fitzgerald et al 1998.	baseline, 3, 6, 9, 12 months	No
Secondary	Changes in Diabetes self-care activities	Changes in diabetes self-care activities from base line to 3, 6, 9, and 12 months will be measured the diabetes self-care activities tool evaluated by Toobert at al (2000).	Baseline, 3, 6, 9 and 12 months	No